Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Braskem SA ( (BAK) ) has shared an announcement.
On December 15, 2025, Braskem S.A. announced that it received communications from Novonor S.A. and Shine I Fundo de Investimento em Direitos Creditórios regarding a definitive binding agreement and an exclusivity agreement. The agreements involve the acquisition of credits held by creditor banks against Novonor, secured by shares in Braskem. The potential transaction could result in an investment fund advised by IG4 Sol. Ltda. acquiring a significant portion of Braskem’s voting and total capital, while Novonor retains a minor stake. This development could impact Braskem’s ownership structure and influence its strategic direction.
The most recent analyst rating on (BAK) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Braskem SA stock, see the BAK Stock Forecast page.
Spark’s Take on BAK Stock
According to Spark, TipRanks’ AI Analyst, BAK is a Neutral.
Braskem SA’s overall stock score reflects significant financial challenges, with high leverage and declining profitability being the most critical factors. While there are some positive aspects, such as improved EBITDA and liquidity, these are overshadowed by ongoing industry pressures and valuation concerns. Technical analysis provides a neutral outlook, with mixed signals on momentum.
To see Spark’s full report on BAK stock, click here.
More about Braskem SA
Braskem S.A. is a publicly held company in the petrochemical industry, primarily engaged in the production of thermoplastic resins. It operates in the chemical and petrochemical sectors, providing products that serve various market needs.
Average Trading Volume: 1,148,562
Technical Sentiment Signal: Sell
Current Market Cap: $1.18B
For detailed information about BAK stock, go to TipRanks’ Stock Analysis page.

